Pediatric bevacizumab minimal PBPK
A minimal PBPK model connecting body-weight-scaled bevacizumab clearance and compartment volumes to central and peripheral antibody exposure.
- Therapeutic
- Bevacizumab
- Target
- Not reported
- Disease
- Pediatric-to-adult bevacizumab exposure bridging
Biological model
A minimal PBPK model connecting body-weight-scaled bevacizumab clearance and compartment volumes to central and peripheral antibody exposure.
Intervention
Bevacizumab
Biological focus
PBPK
Context
Pediatric-to-adult bevacizumab exposure bridging
Model details
A minimal PBPK model connecting body-weight-scaled bevacizumab clearance and compartment volumes to central and peripheral antibody exposure.
Modeled states
- auc mg h lmg*h/L
Modeled dynamic state for auc mg h l.
- central mgmg
Modeled dynamic state for central mg.
- peripheral mgmg
Modeled dynamic state for peripheral mg.
Key readouts
- Central bevacizumab concentrationunknown
Model-derived readout for central bevacizumab concentration.
- Cumulative bevacizumab exposuremg*h/L
Model-derived readout for cumulative bevacizumab exposure.
- Total bevacizumab clearanceunknown
Model-derived readout for total bevacizumab clearance.
- Central distribution volumeunknown
Model-derived readout for central distribution volume.
- central mgmg
Model-derived readout for central mg.
Explore this model
Choose a starting point to view its result. Adjust key model inputs when you want to explore a different outcome.
Female >=18 10 mg/kg every 2 weeks
How does pediatric body weight change bevacizumab compartment volumes, clearance, concentration, and exposure? Explore this intervention regimen through Central bevacizumab concentration, Cumulative bevacizumab exposure, Total bevacizumab clearance, Central distribution volume. This is a mechanistic product exploration, not a paper-result reproduction.
Questions to explore
- How does pediatric body weight change bevacizumab compartment volumes, clearance, concentration, and exposure?
Starting result
This result reflects the starting settings. Run your changes to update it.
Model inputs
Five scientist-facing controls at most.
Compare a parameter
How does one model input change the response?
How does pediatric body weight change bevacizumab compartment volumes, clearance, concentration, and exposure?
body weight kg
Model parameter controlling body weight kg.
Exploratory range around the default value.
5 evenly spaced values in kg. Other model inputs and the simulation window stay fixed.
Interpret with care
- Interpret trajectories as deterministic model behavior, not as a patient-specific prediction or dosing recommendation.
- Paper-result and exact-anchor checks remain in the private validation lane and are not part of this public scenario.
Review the server-confirmed fixed price before starting the comparison.
Comparative response
End-of-window response across the selected parameter values.
Choose an exploratory range around the default, review the fixed price, and run the comparison.
Scientific reference
Supporting publication
Utilizing Minimal Physiologically Based Pharmacokinetic Modeling to Bridge Bevacizumab Pharmacokinetics from Adult to Pediatric PatientsThe AAPS Journal
